
Type-species-anchored Serratia reconstruction with nine straight short rods. Representative, non-diagnostic, and not a micrograph; omitted appendages and colony pigment make no phenotype claim.
Scientific media record1 verified identifier
- Subject
- Serratiataxon · genus
- Identifiers
- NCBITaxon:613
- Review
- Editorial review completeIdentifiers authority-verified · Accessibility validated · · serratia|serratia-morphology-v1.webp
- Digital source
- Trained-algorithmic mediaCreated with a trained generative algorithm and reviewed by WikiBiome for subject identity, scientific framing, identifiers, provenance, and accessibility.
- License
- CC BY-SA 4.0Created
Serratia is a genus of Gram-negative, facultatively anaerobic bacteria in the Enterobacteriaceae family. The primary species is S. marcescens, famous for its red pigment prodigiosin and its role as a nosocomial opportunistic pathogen. In the WikiBiome vault, Serratia appears across reproductive tract, cardiovascular, and oncology contexts.
Evidence map4 cited passagesInspect provenance +
Enterobacteriaceae identification: Part of the Enterobacteriaceae panel relevant to clinical dysbiosis assessment.
Colorectal cancer: Identified in CRC-associated microbiome studies.
Cardiovascular disease: Part of gut microbiota associated with vascular biomarkers in subclinical CVD.
Prostate/reproductive: Present in prostate cancer-associated microbiome and seminal fluid studies.
Key Associations#
Enterobacteriaceae identification: Part of the Enterobacteriaceae panel relevant to clinical Dysbiosis assessment.[1]A Novel Approach for Identification of Members of Enterobacteriaceae Isolated from Clinical SamplesKhan F, Rizvi M, Shukla I et al. · 2011Open reference 1 ↓ Colorectal cancer: Identified in CRC-associated microbiome studies.[2]Towards the Human Colorectal Cancer MicrobiomeMarchesi JR, Dutilh BE, Hall N et al. · 2011Open reference 2 ↓
Cardiovascular disease: Part of gut microbiota associated with vascular biomarkers in subclinical CVD.[3]Gut microbiota and vascular biomarkers in patients without clinical cardiovascular diseasesDaria Kashtanova, Olga Tkacheva, Anna Popenko et al. · 2017Open reference 3 ↓
Prostate/reproductive: Present in prostate cancer-associated microbiome and seminal fluid studies.[4]Trecarten 2025 — Obesity, Dietary Interventions and Microbiome Alterations in Prostate CancerShaun Trecarten, Michael A. Liss, Jill Hamilton-Reeves et al. · 2025Open reference 4 ↓[5]Neto 2024 — Effect of Environmental Factors on Seminal Microbiome and Impact on Sperm QualityFilipe T. Lira Neto, Marina C. Viana, Federica Cariati et al. · 2024Open reference 5 ↓[6]Johri 2023 — Successful Treatment of Recurrent E. coli Infection with Bacteriophage Therapy for Chronic Bacterial ProstatitisApurva Virmani Johri, Pranav Johri, Naomi Hoyle et al. · 2023Open reference 6 ↓
Metal Dependencies#
S. marcescens produces metalloproteases (zinc-dependent) and requires iron for growth. Like other Enterobacteriaceae, it possesses siderophore-mediated iron acquisition systems.
Cross-References#
- Enterobacteriaceae—family-level context
- Iron—siderophore-dependent iron acquisition
References 6
Numbered by first appearance in the article, then reconciled with its declared source list.
- 1
Khan F, Rizvi M, Shukla I et al. (2011). A Novel Approach for Identification of Members of Enterobacteriaceae Isolated from Clinical Samples. Biology and Medicine.
- 2
Marchesi JR, Dutilh BE, Hall N et al. (2011). Towards the Human Colorectal Cancer Microbiome. PLOS ONE.
- 3
Daria Kashtanova, Olga Tkacheva, Anna Popenko et al. (2017). Gut microbiota and vascular biomarkers in patients without clinical cardiovascular diseases. Artery Research.
- 4
Shaun Trecarten, Michael A. Liss, Jill Hamilton-Reeves et al. (2025). Trecarten 2025 — Obesity, Dietary Interventions and Microbiome Alterations in Prostate Cancer. Frontiers in Immunology.
- 5
Filipe T. Lira Neto, Marina C. Viana, Federica Cariati et al. (2024). Neto 2024 — Effect of Environmental Factors on Seminal Microbiome and Impact on Sperm Quality. Frontiers in Endocrinology.
- 6
Apurva Virmani Johri, Pranav Johri, Naomi Hoyle et al. (2023). Johri 2023 — Successful Treatment of Recurrent E. coli Infection with Bacteriophage Therapy for Chronic Bacterial Prostatitis. Frontiers in Pharmacology.
Article network
Mentioned here 3
Connect the evidence
Publicly readable discussion by ORCID-authenticated researchers. Questions, interpretation, methods, corrections, and new evidence stay attached to this record.
No discussion yet. Start with a precise question or a source-backed observation.
Activity and accepted changes
Accepted researcher context, editorial status, public discussion, and upstream Git revisions are shown together. Pending, declined, and withdrawn proposals remain private.
- published revision
Complete corpus-wide Dysbiosis linking
Karen Pendergrass · +1 −1
Inspect exact Git diff ↗ - published revision
massive wiki expansion: 149 stubs fixed, 100+ new pages, Rule 15 scan, keystone papers
WikiBiome Deploy Bot · +47 −0
Inspect exact Git diff ↗

